Published in Clin Chem on February 01, 1978
A novel role for fatty acid transport protein 1 in the regulation of tricarboxylic acid cycle and mitochondrial function in 3T3-L1 adipocytes. J Lipid Res (2009) 0.87
Proinflammatory signal suppresses proliferation and shifts macrophage metabolism from Myc-dependent to HIF1α-dependent. Proc Natl Acad Sci U S A (2016) 0.81
Formation of reactive oxygen species by human and bacterial pyruvate and 2-oxoglutarate dehydrogenase multienzyme complexes reconstituted from recombinant components. Free Radic Biol Med (2015) 0.78
Pyruvate: immunonutritional effects on neutrophil intracellular amino or alpha-keto acid profiles and reactive oxygen species production. Amino Acids (2010) 0.76
MyoD Regulates Skeletal Muscle Oxidative Metabolism Cooperatively with Alternative NF-κB. Cell Rep (2016) 0.76
A mitochondrial encephalomyopathy with a partial cytochrome c oxidase deficiency of muscle. J Neurol Neurosurg Psychiatry (1988) 0.75
Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet (1995) 5.58
A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet (1998) 4.96
Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science (1994) 4.27
Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int (2007) 4.26
Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet (1996) 2.68
Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med (1985) 2.49
Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet (1995) 2.35
New insights into the structure and function of fatty acid-binding proteins. Cell Mol Life Sci (2002) 2.18
Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J (1999) 2.07
Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J Biol Chem (1998) 1.97
Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation. Kidney Int (2007) 1.93
Effects of oral and intramuscular vitamin K prophylaxis on vitamin K1, PIVKA-II, and clotting factors in breast fed infants. Arch Dis Child (1992) 1.86
Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism (1994) 1.81
Mutations in the type IV collagen alpha 3 (COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet (1994) 1.69
Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia (1994) 1.69
Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney Int (1998) 1.66
Identification of COL4A5 defects in Alport's syndrome by immunohistochemistry of skin. Kidney Int (1999) 1.61
The glycosaminoglycan content of renal basement membranes in the congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol (1992) 1.55
Characterization of verocytotoxin-producing Escherichia coli O157 isolates from patients with haemolytic uraemic syndrome in Western Europe. Epidemiol Infect (1995) 1.54
[Prevalence of hemorrhages due to vitamin K deficiency in The Netherlands, 1992-1994]. Ned Tijdschr Geneeskd (1996) 1.54
Elastin as a biomaterial for tissue engineering. Biomaterials (2007) 1.53
A radiochemical procedure for the assay of fatty acid binding by proteins. Anal Biochem (1983) 1.52
Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus. Nat Genet (1992) 1.51
Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood (1996) 1.51
Three-dimensional structure of recombinant human muscle fatty acid-binding protein. J Biol Chem (1992) 1.49
The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment. Am J Hum Genet (1999) 1.48
Prevention of vitamin K deficiency in infancy by weekly administration of vitamin K. Acta Paediatr (1993) 1.47
Occurrence of verocytotoxin-producing Escherichia coli O157 on Dutch dairy farms. J Clin Microbiol (1998) 1.47
A mitochondrial encephalomyopathy: the first case with an established defect at the level of coenzyme Q. Eur J Pediatr (1986) 1.46
Isolation and characterization of verocytotoxin-producing Escherichia coli O157 strains from Dutch cattle and sheep. J Clin Microbiol (1998) 1.45
Folate, homocysteine and neural tube defects: an overview. Exp Biol Med (Maywood) (2001) 1.45
Intraperitoneal administration of recombinant human erythropoietin in children on continuous ambulatory peritoneal dialysis. Eur J Pediatr (1992) 1.44
Fibrinolytic responses to 1-desamino-8-D-arginine-vasopressin in patients with congenital nephrogenic diabetes insipidus. Nephron (1990) 1.42
Defective cystathionine beta-synthase regulation by S-adenosylmethionine in a partially pyridoxine responsive homocystinuria patient. J Clin Invest (1996) 1.42
Adequate dialysis? Measurement of KT/V in a pediatric peritoneal dialysis population. Perit Dial Int (1997) 1.39
Fatty acid binding proteins from different tissues show distinct patterns of fatty acid interactions. Biochemistry (2000) 1.39
Molecular beacons: a new approach for semiautomated mutation analysis. Clin Chem (1998) 1.37
[Evaluation of various forms of vitamin-K prophylaxis in breastfed infants]. Ned Tijdschr Geneeskd (1993) 1.37
Intracellular fatty acid-binding proteins. Int J Biochem (1985) 1.36
Dominant isolated renal magnesium loss is caused by misrouting of the Na(+),K(+)-ATPase gamma-subunit. Nat Genet (2000) 1.35
Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction. Biochem J (1992) 1.35
Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int (1997) 1.35
Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation (1997) 1.35
Fatty acid composition of Bifidobacterium and Lactobacillus strains. J Bacteriol (1971) 1.35
Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol (1999) 1.33
Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. Blood (2000) 1.31
Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene. Am J Hum Genet (1994) 1.30
Structural studies on human muscle fatty acid binding protein at 1.4 A resolution: binding interactions with three C18 fatty acids. Structure (1994) 1.29
Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae. Lancet (1992) 1.27
A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk. J Mol Med (Berl) (2001) 1.26
Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate. Biomaterials (1999) 1.25
Elimination of autofluorescence in immunofluorescence microscopy with digital image processing. J Histochem Cytochem (1995) 1.25
Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. J Biomed Mater Res (2002) 1.23
Benign familial hematuria due to mutation of the type IV collagen alpha4 gene. J Clin Invest (1996) 1.22
14CO2 production is no adequate measure of [14C]fatty acid oxidation. Biochem Med Metab Biol (1986) 1.22
Linkage of chondroitin-sulfate to type I collagen scaffolds stimulates the bioactivity of seeded chondrocytes in vitro. Biomaterials (2001) 1.22
Neural-tube defects and derangement of homocysteine metabolism. N Engl J Med (1991) 1.21
Altered folate and vitamin B12 metabolism in families with spina bifida offspring. QJM (1997) 1.21
Two types of fatty acid-binding protein in human kidney. Isolation, characterization and localization. Biochem J (1991) 1.20
Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta (1988) 1.20
Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane. J Histochem Cytochem (1998) 1.20
A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int (1992) 1.19
Haemolytic-uraemic syndrome. Epidemiological and clinical study. Arch Dis Child (1974) 1.19
Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis--a review. Eur J Pediatr (2009) 1.19
Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects. Biomaterials (2000) 1.18
Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? Mol Genet Metab (2001) 1.18
Leigh's encephalomyelopathy in a patient with cytochrome c oxidase deficiency in muscle tissue. Pediatrics (1977) 1.18
Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome. Pediatr Res (1998) 1.17
Improved identification of heterozygotes for homocystinuria due to cystathionine synthase deficiency by the combination of methionine loading and enzyme determination in cultured fibroblasts. Hum Genet (1985) 1.17
Decreased methylene tetrahydrofolate reductase activity due to the 677C-->T mutation in families with spina bifida offspring. J Mol Med (Berl) (1996) 1.17
Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril (1993) 1.17
Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies. J Neurosci (2000) 1.16
The clinical spectrum of type IV collagen mutations. Hum Mutat (1997) 1.16
Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscler Thromb (1994) 1.14
Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. J Autoimmun (1990) 1.14
Biochemical studies in the liver and muscle of patients with Zellweger syndrome. Pediatr Res (1983) 1.13
Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years. J Clin Invest (1983) 1.13
Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta (1985) 1.11
The activity state of the branched-chain 2-oxo acid dehydrogenase complex in rat tissues. Biochem J (1984) 1.11
Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action. Diabetologia (2000) 1.10
Ligand specificity and conformational stability of human fatty acid-binding proteins. Int J Biochem Cell Biol (2001) 1.09
Pyruvate oxidation in rat and human skeletal muscle mitochondria. Biochem Med (1978) 1.09
Diurnal variation of cytosolic fatty acid-binding protein content and of palmitate oxidation in rat liver and heart. J Biol Chem (1984) 1.08
Investigation of mitochondrial metabolism in small human skeletal muscle biopsy specimens. Improvement of preparation procedure. Clin Chim Acta (1985) 1.08
Differentiation markers of mouse C2C12 and rat L6 myogenic cell lines and the effect of the differentiation medium. In Vitro Cell Dev Biol Anim (1999) 1.07
Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kidney Int (1993) 1.07
Verocytotoxin-producing Escherichia coli infection in hemolytic uremic syndrome in part of western Europe. Eur J Pediatr (1996) 1.07
The effect of malonyl-CoA on fatty acid oxidation in rat muscle and liver mitochondria. Biochim Biophys Acta (1982) 1.06
New mutations in the AQP2 gene in nephrogenic diabetes insipidus resulting in functional but misrouted water channels. J Am Soc Nephrol (1997) 1.05
Incomplete palmitate oxidation in cell-free systems of rat and human muscles. Biochim Biophys Acta (1983) 1.05
Effect of genetic variants of the heart fatty acid-binding protein gene on intramuscular fat and performance traits in pigs. J Anim Sci (1999) 1.04
Quantification and characterization of glycosaminoglycans at the nanogram level by a combined azure A-silver staining in agarose gels. Anal Biochem (1994) 1.04
Fatty-acid-binding proteins do not protect against induced cytotoxicity in a kidney cell model. Biochem J (2001) 1.03
Detection of verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with hemolytic uremic syndrome. J Am Soc Nephrol (2001) 1.03